Security key
471871202
Jasper Therapeutics, Inc. - Voting Common Stock (JSPR)
CUSIP: 471871202
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / Voting Common Stock
- Total 13F shares
- 13,034,173
- Total 13F value
- $56,047,183
- Share change
- -2,590,135
- Put/Call ratio
- 70%
- SEC-reported price per share
- $4.30
- Number of holders
- 66
- Value change
- -$70,633,595
- Number of buys
- 29
- Number of sells
- 51
- Shares outstanding
- 27,779,583
Holder snapshot
7 signals
Show 1 more signal
Security identity
1 source field
Report period
Q1 2025
Institutions
66
Top holders
10
JSPR full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2025
Previous quarter: Q4 2024
Jasper Therapeutics, Inc. SEC filings
Jasper Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 471871202
Recent filing periods:
Ownership snapshot
Top reported holders of JSPR - Jasper Therapeutics, Inc. - Voting Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Soleus Capital Management...
Disclosed value leader
Soleus Capital Management...
Comparable rows
15/15
Latest evidence
31 Dec 2024
13F
3/4/5
Lead comparable stake: 5.4%
Showing 1-6 of 15 holder rows.
Quick read
Soleus Capital Management, L.P. leads the comparable SEC ownership view at 5.4%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
Soleus Capital Management, L.P.
5.4%
Velan Capital Investment Manageme...
5.2%
Carlyle Group Inc.
3.8%
Qiming U.S. Ventures Management, LLC
3.3%
BlackRock, Inc.
2.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Soleus Capital Management, L.P. |
13F
Company
|
5.4%
|
$31,950,700
1,494,420 shares
|
— | 31 Dec 2024 |
| Velan Capital Investment Management LP |
13F
3/4/5
Company · 10%+ Owner
|
5.2%
|
$30,655,243
1,433,828 shares
|
— | 31 Dec 2024 |
| Carlyle Group Inc. |
13F
3/4/5
Company · Former 10% Owner
|
3.8%
|
$22,667,178
1,066,189 shares
|
— | 31 Dec 2024 |
| Qiming U.S. Ventures Management, LLC |
13F
Company
|
3.3%
|
$19,861,250
928,964 shares
|
— | 31 Dec 2024 |
| BlackRock, Inc. |
13F
Company
|
2.9%
|
$17,276,878
808,086 shares
|
— | 31 Dec 2024 |
| BRAIDWELL LP |
13F
Company
|
2.6%
|
$15,279,388
714,658 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
66
Shares
13,034,173
Rows available
66
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
84
Q1 2025 holders
66
Holder diff
-18
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 value | Q1 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend